Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles

• Thaís Dolzany de Oliveira,
• Thaís Dolzany de Oliveira,
• Thaís Dolzany de Oliveira,
• Alexander vom Stein,
• Alexander vom Stein,
• Alexander vom Stein,
• Rocio Rebollido-Rios,
• Rocio Rebollido-Rios,
• Rocio Rebollido-Rios,
• Liudmila Lobastova,
• Liudmila Lobastova,
• Liudmila Lobastova,
• Marcus Lettau,
• Marcus Lettau,
• Ottmar Janssen,
• Prerana Wagle,
• Phuong-Hien Nguyen,
• Phuong-Hien Nguyen,
• Phuong-Hien Nguyen,
• Michael Hallek,
• Michael Hallek,
• Michael Hallek,
• Hinrich P. Hansen,
• Hinrich P. Hansen,
• Hinrich P. Hansen

Affiliations

Thaís Dolzany de Oliveira

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Thaís Dolzany de Oliveira

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Thaís Dolzany de Oliveira

CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany

Alexander vom Stein

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Alexander vom Stein

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Alexander vom Stein

CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany

Rocio Rebollido-Rios

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Rocio Rebollido-Rios

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Rocio Rebollido-Rios

CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany

Liudmila Lobastova

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Liudmila Lobastova

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Liudmila Lobastova

CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany

Marcus Lettau

Institute of Immunology, University Hospital Schleswig-Holstein, Christian-Albrecht University of Kiel, Kiel, Germany

Marcus Lettau

Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany

Ottmar Janssen

Institute of Immunology, University Hospital Schleswig-Holstein, Christian-Albrecht University of Kiel, Kiel, Germany

Prerana Wagle

CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Proteomics Facility, University of Cologne, Cologne, Germany

Phuong-Hien Nguyen

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Phuong-Hien Nguyen

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Phuong-Hien Nguyen

CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany

Michael Hallek

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Michael Hallek

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Michael Hallek

CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany

Hinrich P. Hansen

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Hinrich P. Hansen

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Hinrich P. Hansen

CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany